The fund will continue the firm's strategy of investing in lower- and middle-market healthcare companies across the United States. Its investment focus is on businesses that can improve operational efficiency, control healthcare costs, and support the delivery of high-quality patient care. Through these investments, Consonance aims to partner with healthcare companies to support sustainable growth and long-term business development.

The fundraising received strong support from existing investors, while also attracting a select group of new investors. The investor base includes a diverse range of global institutional investors, such as endowments, foundations, pension plans, and financial institutions. The strong participation reflects investor interest in the firm's healthcare-focused investment strategy, although the announcement does not disclose the exact amount of excess demand.

Consonance Capital Partners employs several investment approaches, including growth equity, leveraged buyouts, corporate carve-outs, recapitalizations, and special-situation transactions. These strategies enable the firm to provide capital for business expansion, support ownership transitions, and pursue investment opportunities involving healthcare companies with specific operational or financial needs. The firm emphasizes working with management teams to build businesses that contribute to a more efficient healthcare system while maintaining a focus on quality and cost-effective care. In connection with the fund's closing, Monument Group served as the global placement agent, assisting with fundraising and investor engagement, while Latham & Watkins LLP acted as legal counsel. The successful closing expands Consonance Capital Partners' investment capacity and enables the firm to pursue further opportunities in the U.S. healthcare sector under its established investment strategy.